ATM and breast cancer: Although ATM heterozygosity in relatives on average was estimated to infer a significant 2.9-fold increased risks for breast cancer, if causal, our data did not convincingly point to a trend of increasing risk with each increment in the probability of being an ATM mutation carrier.